Day: May 13, 2020

Scienjoy Inc. Reports First Quarter 2020 Financial Results

BEIJING, May 14, 2020 /PRNewswire/ — Scienjoy Inc. (“Scienjoy”, the “Company”, or “We”), a leading live entertainment mobile streaming platform in China and a wholly owned subsidiary of Scienjoy Holdings Corporation (NASDAQ: SJ), today announced its unaudited financial results for the first quarter ended March 31, 2020. On May 7, 2020, Scienjoy Inc. merged with […]

VolitionRx To Present First Data on Nu.Q™ Capture Performance and Nu.Q™ Assay Performance in Lung Cancer and Blood Cancer at the 2020 ASCO Annual Meeting

AUSTIN, Texas, May 14, 2020 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), an epigenetics company developing simple, easy to use and cost effective blood tests to help diagnose a range of cancers, will present three abstracts at the 2020 ASCO Annual Meeting. The first abstract presented announces initial data demonstrating the ability of Volition’s […]

Frost & Sullivan Assesses the Top 21 Global Risks that Threaten the Next Decade

Inability to mitigate global risks such as rise of infectious diseases like COVID-19 can adversely impact businesses, societies, and economies SANTA CLARA, California, May 14, 2020 /PRNewswire/ — Frost & Sullivan’s recent analysis, Global Future Risks—Future-proofing Your Strategies, 2030, provides a compelling analysis that will help stakeholders understand the impact of future risks through the short, […]

Hetero Enters Into a Licensing Agreement With Gilead Sciences, Inc. for the Manufacturing and Distribution of “Remdesivir” in 127 Countries, Including India, for COVID-19

HYDERABAD, India, May 14, 2020 /PRNewswire/ — Hetero, one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs, announced today that it has entered into a licensing agreement with Gilead Sciences, Inc. for the manufacturing and distribution of “Remdesivir” for the treatment of Covid-19. Under this licensing deal, Hetero will […]

Telehealth to Experience Massive Growth with COVID-19 Pandemic, Says Frost & Sullivan

Demand for telehealth will soar by 64.3% in the US in 2020 as the COVID-19 pandemic disrupts the practice of medicine and the delivery of healthcare SANTA CLARA, California, May 14, 2020 /PRNewswire/ — Frost & Sullivan’s recent analysis, Telehealth—A Technology-Based Weapon in the War Against the Coronavirus, 2020, finds that the demand for telehealth technology […]

Back To Top